Current approaches and questions yet to be resolved for the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis

doi:10.4253/wjge.v14.i11.657

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3040)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

189

WORD

HTML

1609

Tables (1-3)

253

Sum=2082

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

306

Download

652

Sum=958

Nov 16, 2022 (publication date) through Jan 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Gastrointest Endosc. Nov 16, 2022; 14(11): 657-666
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.657

Table 2 Recommended strategies for suspected common bile duct stones in patients with symptomatic cholelithiasis based on the ESGE and ASGE guidelines

ESGE guideline			ASGE guideline
Likelihood	Predictors	Recommended strategy	Predictors	Recommended strategy
Low	Normal liver function tests and no CBD dilation at US	Proceed to cholecystectomy	No predictors	Cholecystectomy with/without laparoscopic cholangiography (IOC) or intraoperative US
Intermediate	Abnormal liver function tests and/or dilated CBD on US	Perform EUS/MRCP	Abnormal liver function tests or age > 55 years or dilated CBD on US/cross-sectional imaging	Perform EUS/MRCP, laparoscopic IOC, or intraoperative US
High	CBDSs identified at US or features of cholangitis	Proceed to ERCP	CBDSs identified at US/cross-sectional imaging	Proceed to ERCP
High	CBDSs identified at US or features of cholangitis	Proceed to ERCP	or features of cholangitis or dilated CBD with total bilirubin > 4 mg/dL on US/cross-sectional imaging	Proceed to ERCP

ASGE: American Society for Gastrointestinal Endoscopy; CBD: Common bile duct; CBDSs: Common bile duct stones; ERCP: Endoscopic retrograde cholangiopancreatography; ESGE: European Society of Gastrointestinal Endoscopy; EUS: Endoscopic ultrasonography; MRCP: Magnetic resonance cholangiopancreatography; US: Ultrasonography.

Citation: Saito H, Fujimoto A, Oomoto K, Kadowaki Y, Tada S. Current approaches and questions yet to be resolved for the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc 2022; 14(11): 657-666
URL: https://www.wjgnet.com/1948-5190/full/v14/i11/657.htm
DOI: https://dx.doi.org/10.4253/wjge.v14.i11.657